626 Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865K Buy
14,261
+4,393
+45% +$256K 0.39% 44
2025
Q4
$532K Sell
9,868
-214
-2% -$10.3K 0.23% 60
2025
Q3
$455K Buy
10,082
+10
+0.1% +$467 0.2% 70
2025
Q2
$466K Sell
10,072
-154
-2% -$7.56K 0.22% 67
2025
Q1
$624K Buy
10,226
+173
+2% +$10.1K 0.32% 51
2024
Q4
$569K Buy
10,053
+699
+7% +$39.1K 0.31% 55
2024
Q3
$484K Sell
9,354
-60
-0.6% -$2.81K 0.27% 62
2024
Q2
$391K Sell
9,414
-375
-4% -$16.8K 0.23% 72
2024
Q1
$531K Sell
9,789
-876
-8% -$44.6K 0.32% 56
2023
Q4
$547K Sell
10,665
-40
-0.4% -$2.1K 0.36% 50
2023
Q3
$621K Sell
10,705
-249
-2% -$15.3K 0.42% 50
2023
Q2
$701K Sell
10,954
-218
-2% -$14.6K 0.45% 42
2023
Q1
$774K Sell
11,172
-87
-0.8% -$6.14K 0.51% 44
2022
Q4
$810K Buy
11,259
+11
+0.1% +$829 0.56% 41
2022
Q3
$800K Buy
11,248
+11
+0.1% +$798 0.65% 37
2022
Q2
$864K Buy
11,237
+11
+0.1% +$838 0.66% 32
2022
Q1
$820K Sell
11,226
-141
-1% -$9.47K 0.53% 42
2021
Q4
$709K Buy
+11,367
New +$667K 0.43% 44
2021
Q1
$820K Buy
+11,226
New +$698K 0.53% 42

Other funds holding BMY